Medmen Enterprises (CNSX:MMEN) had its price objective boosted by Canaccord Genuity to $0.40 in a research note issued to investors on Friday morning, Stock Target Advisor reports. Canaccord Genuity currently has a hold rating on the stock.
About Medmen Enterprises
MedMen Enterprises Inc, together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states.
Recommended Story: What is a Market Correction?
Receive News & Ratings for Medmen Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medmen Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.